Testing effectiveness (Phase 2)Looking for participantsNCT04864054
What this trial is testing
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
Who this might be right for
Hepatocellular CarcinomaLiver Cancer, AdultLiver Neoplasm+1 more
Eureka Therapeutics Inc. 60